Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
kānuka honey is a medical-grade botanical extract derived from the nectar of the *Kunzea ericoides* tree, native to New Zealand. Developed by HoneyLab under the brand name Honevo, it is processed to ensure high levels of sterility and standardized antimicrobial activity. Unlike Manuka honey, which is characterized by methylglyoxal (MGO), kānuka honey's primary antimicrobial mechanism is attributed to high concentrations of hydrogen peroxide. It also contains unique phenolic compounds that contribute to its anti-inflammatory and antiviral properties. HoneyLab has investigated the topical application of kānuka honey in clinical trials for the treatment of skin conditions including rosacea, acne, and herpes simplex labialis (cold sores), often demonstrating efficacy comparable to standard treatments like aciclovir or topical antibiotics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kānuka honey.